| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 36478 |
|
18,459 |
13,671 |
$28.33M |
| 93229 |
|
20,174 |
20,126 |
$16.90M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
64,329 |
64,141 |
$14.14M |
| 36465 |
|
7,537 |
6,499 |
$11.80M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
125,010 |
120,596 |
$10.39M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
15,572 |
15,229 |
$6.55M |
| 93970 |
|
29,780 |
29,645 |
$5.97M |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
15,477 |
14,932 |
$5.09M |
| 33285 |
|
891 |
891 |
$4.19M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
22,126 |
22,067 |
$2.85M |
| 93971 |
|
24,114 |
18,539 |
$2.84M |
| J2785 |
Injection, regadenoson, 0.1 mg |
12,597 |
12,490 |
$2.43M |
| 93351 |
|
7,748 |
7,744 |
$2.31M |
| 93925 |
|
12,028 |
11,984 |
$2.15M |
| 93880 |
|
9,042 |
9,031 |
$1.61M |
| 93015 |
|
18,390 |
18,188 |
$1.47M |
| 93000 |
|
61,442 |
60,479 |
$1.22M |
| 93356 |
|
28,999 |
28,980 |
$1.12M |
| 99215 |
Prolong outpt/office vis |
7,027 |
6,969 |
$904K |
| 93298 |
|
24,166 |
24,002 |
$883K |
| 93922 |
|
12,674 |
10,809 |
$877K |
| 93224 |
|
5,870 |
5,848 |
$703K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,120 |
9,897 |
$613K |
| 99233 |
Prolong inpt eval add15 m |
8,205 |
4,482 |
$570K |
| 93228 |
|
20,006 |
19,956 |
$522K |
| 78451 |
|
1,362 |
1,039 |
$409K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
14,242 |
14,229 |
$391K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,881 |
1,759 |
$288K |
| 99205 |
Prolong outpt/office vis |
1,679 |
1,677 |
$280K |
| 93975 |
|
1,118 |
1,116 |
$277K |
| 99223 |
Prolong inpt eval add15 m |
1,704 |
1,673 |
$218K |
| 93978 |
|
1,354 |
1,352 |
$210K |
| 93280 |
|
1,477 |
1,464 |
$82K |
| 93930 |
|
472 |
472 |
$73K |
| 93297 |
|
2,177 |
2,163 |
$57K |
| J7050 |
Infusion, normal saline solution, 250 cc |
17,918 |
17,195 |
$41K |
| 93299 |
|
1,834 |
1,724 |
$40K |
| 93458 |
|
156 |
152 |
$39K |
| 93283 |
|
416 |
415 |
$37K |
| 99152 |
|
1,330 |
1,290 |
$37K |
| 93296 |
|
1,319 |
1,311 |
$31K |
| 37765 |
|
54 |
53 |
$24K |
| 92971 |
|
277 |
26 |
$24K |
| 37252 |
|
54 |
52 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
231 |
231 |
$23K |
| 93295 |
|
424 |
422 |
$18K |
| 33286 |
|
155 |
154 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
411 |
405 |
$17K |
| 99406 |
|
972 |
956 |
$13K |
| 36140 |
|
214 |
197 |
$11K |
| 93613 |
|
38 |
38 |
$11K |
| 93294 |
|
473 |
470 |
$10K |
| 93290 |
|
264 |
261 |
$10K |
| 36471 |
|
53 |
46 |
$8K |
| 75635 |
|
52 |
50 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
116 |
13 |
$4K |
| 37253 |
|
13 |
12 |
$3K |
| 76942 |
|
38 |
34 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
31 |
31 |
$2K |
| 36246 |
|
17 |
15 |
$2K |
| 76937 |
|
184 |
179 |
$2K |
| 76706 |
|
15 |
15 |
$2K |
| 93662 |
|
13 |
13 |
$2K |
| 93284 |
|
15 |
15 |
$2K |
| 93041 |
|
115 |
12 |
$684.45 |
| 93279 |
|
12 |
12 |
$395.78 |
| 3075F |
|
1,478 |
1,469 |
$28.88 |
| 3077F |
|
2,645 |
2,582 |
$28.70 |
| 3079F |
|
1,663 |
1,649 |
$0.32 |
| 3080F |
|
432 |
426 |
$0.00 |
| 3074F |
|
5,185 |
5,103 |
$0.00 |
| 3078F |
|
8,503 |
8,346 |
$0.00 |